Eledon Pharmaceuticals, Inc. Accrued Liabilities, Current
Eledon Pharmaceuticals, Inc. (ELDN) had Accrued Liabilities, Current of $1.49 million as of 2017-06-30, per its 10-Q filed 2017-08-09.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2017-08-09
- 2017-06-30: Accrued Liabilities, Current $1.49M.
- 2017-03-31: Accrued Liabilities, Current $2.14M.
- 2016-12-31: Accrued Liabilities, Current $113.00K; Accrued Liabilities, Current as first filed $2.39M.
- 2016-09-30: Accrued Liabilities, Current $5.46M.
| Period end | Accrued Liabilities, Current | Accrued Liabilities, Current as first filed |
|---|---|---|
| 2017-06-30 | $1.49M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $2.14M 10-Q · filed 2017-05-03 | |
| 2016-12-31 | $113.00K 10-Q · filed 2017-08-09 | $2.39M 10-K · filed 2017-03-03 |
| 2016-09-30 | $5.46M 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $5.97M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $4.29M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $4.95M 10-K · filed 2017-03-03 | |
| 2015-09-30 | $4.00M 10-Q · filed 2015-11-10 | |
| 2015-06-30 | $2.94M 10-Q · filed 2015-08-12 | |
| 2015-03-31 | $2.32M 10-Q · filed 2015-05-12 | |
| 2014-12-31 | $3.48M 10-K · filed 2016-03-10 | |
| 2014-09-30 | $2.48M 10-Q · filed 2014-11-13 | |
| 2013-12-31 | $2.20M 10-K · filed 2015-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |